1 / 8

Tools and Knowledge Sharing to Drive Acne Medication Market by 2025

The Global Acne Medication Market was valued at $8,017 million in 2017, and is projected to reach $10,929 million by 2025 at a CAGR of 3.9% from 2018 to 2025. The study provides an in-depth analysis of the global acne medication market with current trends and future estimations from 2017 to 2025 to elucidate the imminent investment pockets.<br><br>Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided. Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

allied123
Download Presentation

Tools and Knowledge Sharing to Drive Acne Medication Market by 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Opportunity Analysis and Industry Forecast, 2016-2023 Acne Medication Market is Witnessing Phenomenal Growth by 2025 Global Opportunity Analysis and Industry Forecast, 2018-2025

  2. Acne Medication Market  Acne medications have gained a substantial market share in the recent years, due to high prevalence of acne vulgaris and high preferences for skin care products. Improved features of acne drugs and development of safer acne therapeutics have led to widening of applications of these medications for the treatment of acne, which have further supplemented the market growth. Furthermore, increase in strategic developments by key players is anticipated to fuel the market growth in the near future

  3. Acne Medication Market Overview According to a new report published by Allied Market Research, titled, Acne Medication Market, by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2018-2025," the global acne medication market was valued at $8,017 million in 2017, and is projected to reach $10,929 million by 2025, registering a CAGR of 3.9% from 2018 to 2025. Access Full Summary at: https://www.alliedmarketresearch.com/acne-medication-market Acne is a long-term skin disease that appears because of clogged hair follicles, dead skin cells, and oil excreted from skin. It is characterized by the presence of considerable number of pimples, whiteheads, blackheads, oily skin, and probable scarring. 

  4. Acne Medication Market Dynamics Increase in prevalence of acne vulgaris condition, especially in teenagers and adults drive the market growth. Other factors that boost the market growth include rise in adoption of skin care products, and unhealthy urban lifestyle that leads to acne development. However, factors such as side effects associated with medicines and presence of alternative acne treatment options such as laser therapies, hamper the market growth. Conversely, the development of effective therapeutics with lesser side effects and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market. 

  5. Acne Medication Market Segmentation The global acne medication market is segmented into therapeutic class, formulation, type, acne type, distribution channel, and region. Based on therapeutic class, the market is divided into retinoids, antibiotics, salicylic acid, benzoyl peroxide, and others. Retinoids segment is further divided into topical retinoid & combination retinoid and oral retinoid (isotretinoin). On the other hand, antibiotics segment is further sub-segmented into topical antibiotics & combination antibiotics, and oral antibiotics. Retinoids segment accounted for the largest market share in 2017, and is expected to continue this trend throughout the forecast period owing to high adoption of retinoids products and less side effects associated with retinoids. On the other hand, salicylic acid segment is anticipated to grow at a significant CAGR of 4.2% during the forecast period.

  6. Acne Medication Market Key Players • Allergan Plc • Nestle S.A. (Galderma S.A.) • Johnson & Johnson • Mayne Pharma Group Limited • Mylan N.V. • Pfizer Inc. • GlaxoSmithKline Plc (Stiefel Laboratories, Inc.) • Sun Pharmaceutical Industries Limited • Teva Pharmaceutical Industries Ltd. • Valeant Pharmaceuticals International, Inc. 

  7. Acne Medication Market North America Europe Asia-Pacific LAMEA

  8. Acne Medication Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request-sample/4356 Follow Us On

More Related